Growth Metrics

OptimizeRx (OPRX) Net Cash Flow (2016 - 2026)

OptimizeRx's Net Cash Flow history spans 16 years, with the latest figure at $3.8 million for Q4 2025.

  • On a quarterly basis, Net Cash Flow rose 240.06% to $3.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $10.0 million, a 2215.47% increase, with the full-year FY2025 number at $10.0 million, up 2215.47% from a year prior.
  • Net Cash Flow hit $3.8 million in Q4 2025 for OptimizeRx, up from $2.9 million in the prior quarter.
  • Over the last five years, Net Cash Flow for OPRX hit a ceiling of $71.8 million in Q1 2021 and a floor of -$46.1 million in Q3 2022.
  • Historically, Net Cash Flow has averaged $642395.4 across 5 years, with a median of $624061.5 in 2021.
  • Biggest five-year swings in Net Cash Flow: soared 2070.07% in 2021 and later crashed 6068.58% in 2022.
  • Tracing OPRX's Net Cash Flow over 5 years: stood at -$374808.0 in 2021, then crashed by 6068.58% to -$23.1 million in 2022, then surged by 117.0% to $3.9 million in 2023, then plummeted by 169.87% to -$2.7 million in 2024, then surged by 240.06% to $3.8 million in 2025.
  • Business Quant data shows Net Cash Flow for OPRX at $3.8 million in Q4 2025, $2.9 million in Q3 2025, and $12000.0 in Q2 2025.